Cargando…

HIV prevalence, engagement in care, and risk behavior among trans women, San Francisco: Evidence of recent successes and remaining challenges

BACKGROUND: Trans women have high HIV prevalence and lag behind 90–90-90 targets for HIV care. In San Francisco in 2017, 96% of trans women were aware of their status, 75% were on antiretroviral therapy, 88% had viral suppression. Initiatives to address gaps include peer navigators, free gender-affi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Izzy, Leathers, Matisse, Cano, Damiana, Turner, Caitlin M, Trujillo, Dillon, Sicro, Sofia, Arayasirikul, Sean, Taylor, Kelly D, Wilson, Erin C, McFarland, Willi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607899/
https://www.ncbi.nlm.nih.gov/pubmed/35816424
http://dx.doi.org/10.1177/09564624221111278
_version_ 1784818655615254528
author Chiu, Izzy
Leathers, Matisse
Cano, Damiana
Turner, Caitlin M
Trujillo, Dillon
Sicro, Sofia
Arayasirikul, Sean
Taylor, Kelly D
Wilson, Erin C
McFarland, Willi
author_facet Chiu, Izzy
Leathers, Matisse
Cano, Damiana
Turner, Caitlin M
Trujillo, Dillon
Sicro, Sofia
Arayasirikul, Sean
Taylor, Kelly D
Wilson, Erin C
McFarland, Willi
author_sort Chiu, Izzy
collection PubMed
description BACKGROUND: Trans women have high HIV prevalence and lag behind 90–90-90 targets for HIV care. In San Francisco in 2017, 96% of trans women were aware of their status, 75% were on antiretroviral therapy, 88% had viral suppression. Initiatives to address gaps include peer navigators, free gender-affirming surgery, and housing. Our study updates HIV prevalence and engagement in care among trans women. METHODS: Cross-sectional community-based survey of trans women living in San Francisco sampled by respondent-driven sampling, 7/2019–2/2020 (N = 201). Eligibility was: self-identified trans women or other gender and assigned male at birth; living in San Francisco; English/Spanish-speaking; and 18 years or older. RESULTS: HIV prevalence was 42.3% (95%CI 35.4.-49.4) and associated with having a partner who injected drugs (adjusted odds ratio [AOR] 3.30, 95%CI 1.58–6.90), ever injected drugs (AOR 2.28, 95%CI 1.06–4.89), cost not a barrier to healthcare (AOR 2.63, 95%CI 1.02–6.67), emotional support from family (AOR 2.85, 95%CI 1.43–5.65), and Black/African-American (AOR 2.59, 95%CI 1.16–5.79). Of trans women with HIV, 92.9% were previously diagnosed, 89.9% were on ART, 91.5% reported viral suppression. CONCLUSIONS: Trans women met 90–90–90 targets in 2020, at 93–90–92. Interventions need to reach Black/African-American trans women, trans women who inject drugs, and partners of trans women.
format Online
Article
Text
id pubmed-9607899
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-96078992022-10-28 HIV prevalence, engagement in care, and risk behavior among trans women, San Francisco: Evidence of recent successes and remaining challenges Chiu, Izzy Leathers, Matisse Cano, Damiana Turner, Caitlin M Trujillo, Dillon Sicro, Sofia Arayasirikul, Sean Taylor, Kelly D Wilson, Erin C McFarland, Willi Int J STD AIDS Original Research Articles BACKGROUND: Trans women have high HIV prevalence and lag behind 90–90-90 targets for HIV care. In San Francisco in 2017, 96% of trans women were aware of their status, 75% were on antiretroviral therapy, 88% had viral suppression. Initiatives to address gaps include peer navigators, free gender-affirming surgery, and housing. Our study updates HIV prevalence and engagement in care among trans women. METHODS: Cross-sectional community-based survey of trans women living in San Francisco sampled by respondent-driven sampling, 7/2019–2/2020 (N = 201). Eligibility was: self-identified trans women or other gender and assigned male at birth; living in San Francisco; English/Spanish-speaking; and 18 years or older. RESULTS: HIV prevalence was 42.3% (95%CI 35.4.-49.4) and associated with having a partner who injected drugs (adjusted odds ratio [AOR] 3.30, 95%CI 1.58–6.90), ever injected drugs (AOR 2.28, 95%CI 1.06–4.89), cost not a barrier to healthcare (AOR 2.63, 95%CI 1.02–6.67), emotional support from family (AOR 2.85, 95%CI 1.43–5.65), and Black/African-American (AOR 2.59, 95%CI 1.16–5.79). Of trans women with HIV, 92.9% were previously diagnosed, 89.9% were on ART, 91.5% reported viral suppression. CONCLUSIONS: Trans women met 90–90–90 targets in 2020, at 93–90–92. Interventions need to reach Black/African-American trans women, trans women who inject drugs, and partners of trans women. SAGE Publications 2022-07-11 2022-10 /pmc/articles/PMC9607899/ /pubmed/35816424 http://dx.doi.org/10.1177/09564624221111278 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research Articles
Chiu, Izzy
Leathers, Matisse
Cano, Damiana
Turner, Caitlin M
Trujillo, Dillon
Sicro, Sofia
Arayasirikul, Sean
Taylor, Kelly D
Wilson, Erin C
McFarland, Willi
HIV prevalence, engagement in care, and risk behavior among trans women, San Francisco: Evidence of recent successes and remaining challenges
title HIV prevalence, engagement in care, and risk behavior among trans women, San Francisco: Evidence of recent successes and remaining challenges
title_full HIV prevalence, engagement in care, and risk behavior among trans women, San Francisco: Evidence of recent successes and remaining challenges
title_fullStr HIV prevalence, engagement in care, and risk behavior among trans women, San Francisco: Evidence of recent successes and remaining challenges
title_full_unstemmed HIV prevalence, engagement in care, and risk behavior among trans women, San Francisco: Evidence of recent successes and remaining challenges
title_short HIV prevalence, engagement in care, and risk behavior among trans women, San Francisco: Evidence of recent successes and remaining challenges
title_sort hiv prevalence, engagement in care, and risk behavior among trans women, san francisco: evidence of recent successes and remaining challenges
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607899/
https://www.ncbi.nlm.nih.gov/pubmed/35816424
http://dx.doi.org/10.1177/09564624221111278
work_keys_str_mv AT chiuizzy hivprevalenceengagementincareandriskbehavioramongtranswomensanfranciscoevidenceofrecentsuccessesandremainingchallenges
AT leathersmatisse hivprevalenceengagementincareandriskbehavioramongtranswomensanfranciscoevidenceofrecentsuccessesandremainingchallenges
AT canodamiana hivprevalenceengagementincareandriskbehavioramongtranswomensanfranciscoevidenceofrecentsuccessesandremainingchallenges
AT turnercaitlinm hivprevalenceengagementincareandriskbehavioramongtranswomensanfranciscoevidenceofrecentsuccessesandremainingchallenges
AT trujillodillon hivprevalenceengagementincareandriskbehavioramongtranswomensanfranciscoevidenceofrecentsuccessesandremainingchallenges
AT sicrosofia hivprevalenceengagementincareandriskbehavioramongtranswomensanfranciscoevidenceofrecentsuccessesandremainingchallenges
AT arayasirikulsean hivprevalenceengagementincareandriskbehavioramongtranswomensanfranciscoevidenceofrecentsuccessesandremainingchallenges
AT taylorkellyd hivprevalenceengagementincareandriskbehavioramongtranswomensanfranciscoevidenceofrecentsuccessesandremainingchallenges
AT wilsonerinc hivprevalenceengagementincareandriskbehavioramongtranswomensanfranciscoevidenceofrecentsuccessesandremainingchallenges
AT mcfarlandwilli hivprevalenceengagementincareandriskbehavioramongtranswomensanfranciscoevidenceofrecentsuccessesandremainingchallenges